(Total Views: 522)
Posted On: 05/05/2025 3:37:19 PM
Post# of 154875
Thanks ohm for the reply.
How do you think the combination b/w SG and LL proves out in the murine study?
Do you think the mOS is increased over SG's 11 months with the addition of LL? to LL's mOS?
If we were to triple SG's mOS from 11 months to 3 years, would that qualify for novel drug and patent extension?
if so, what do you think the chances are that G makes an offer and what do you think that offer would be?
Let's say the offer was for somewhere what they paid for SG, but stipulated with the condition to abandon HIV, how would that go over?
How do you think the combination b/w SG and LL proves out in the murine study?
Do you think the mOS is increased over SG's 11 months with the addition of LL? to LL's mOS?
If we were to triple SG's mOS from 11 months to 3 years, would that qualify for novel drug and patent extension?
if so, what do you think the chances are that G makes an offer and what do you think that offer would be?
Let's say the offer was for somewhere what they paid for SG, but stipulated with the condition to abandon HIV, how would that go over?
(3)
(0)
